|
ABCC5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.793600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.370200E-01 |
| Normal-vs-Stage2 |
3.873000E-01 |
| Normal-vs-Stage3 |
3.686000E-02 |
| Normal-vs-Stage4 |
9.593600E-01 |
| Stage1-vs-Stage2 |
6.847700E-02 |
| Stage1-vs-Stage3 |
1.457190E-01 |
| Stage1-vs-Stage4 |
7.562400E-01 |
| Stage2-vs-Stage3 |
1.385880E-02 |
| Stage2-vs-Stage4 |
7.783000E-01 |
| Stage3-vs-Stage4 |
4.888800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.806400E-01 |
| Normal-vs-AfricanAmerican |
9.040600E-01 |
| Normal-vs-Asian |
7.117400E-01 |
| Caucasian-vs-AfricanAmerican |
4.840800E-01 |
| Caucasian-vs-Asian |
4.343400E-01 |
| AfricanAmerican-vs-Asian |
6.292000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.872000E-01 |
| Normal-vs-Female |
2.446800E-01 |
| Male-vs-Female |
2.177800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.074400E-01 |
| Normal-vs-Extreme_Weight |
2.007000E-01 |
| Normal-vs-Obese |
3.070400E-01 |
| Normal-vs-Extreme_Obese |
6.271600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.599600E-01 |
| Normal_Weight-vs-Obese |
4.764200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.643600E-01 |
| Extreme_Weight-vs-Obese |
7.718800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.457600E-01 |
| Obese-vs-Extreme_Obese |
3.994400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.911400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.087200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.570600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.015680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.251600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.998200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.183610E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.206000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.630400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.938200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.764400E-01 |
| Normal-VS-Type2 PRCC |
3.958100E-04 |
| Normal-VS-KIRP CIMP |
1.467990E-01 |
| Normal-VS-Unclassified PRCC |
8.422600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.72799999864637E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.814840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.806000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.967800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.757600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.719970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.320400E-02 |
| Normal-vs-N1 |
2.622200E-01 |
| Normal-vs-N2 |
6.107800E-01 |
| N0-vs-N1 |
7.706000E-01 |
| N0-vs-N2 |
5.112000E-01 |
| N1-vs-N2 |
5.293200E-01 |
|
|
